Emulsifying ointment

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)

العنصر النشط:

Liquid paraffin; White soft paraffin; Emulsifying wax

متاح من:

A A H Pharmaceuticals Ltd

ATC رمز:

n/a

INN (الاسم الدولي):

Liquid paraffin; White soft paraffin; Emulsifying wax

جرعة:

200mg/1gram ; 500mg/1gram ; 300mg/1gram

الشكل الصيدلاني:

Cutaneous ointment

طريقة التعاطي:

Cutaneous

الفئة:

No Controlled Drug Status

نوع الوصفة الطبية :

Valid as a prescribable product

ملخص المنتج:

BNF: 13020100; GTIN: 5025903004783

نشرة المعلومات

keyline
text free area
164.363 mm
39.81 mm
159.407 mm
Braille Translation:
EMULSIFYING
OINTMENT BP
EMULSIFYING
OINTMENT BP
EMULSIFYING
OINTMENT BP

خصائص المنتج

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Emulsifying Ointment BP.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Emulsifying Wax
30%
White Soft Paraffin
50%
Liquid Paraffin
20%
Wax as prepared in section 6.1
3.
PHARMACEUTICAL FORM
Ointment
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For external use only.
Used to prepare Aqueous Cream BP and Buffered Cream BP.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
The product is used by the pharmacist to prepare Aqueous Cream and
Buffered Cream and therefore is not sold with any clinical indications
or
dosage schedules.
4.3.
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
Emulsifying ointment has been found to have major sunscreen activity
in
clinically normal skin. Preparations containing emulsifying ointment
should
not be used before phototherapy or in phototesting procedures.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
For external use only.
Emulsifying wax (which contains sodium lauryl sulphate and cetostearyl
alcohol) may cause local skin reactions (e.g. stinging, burning,
itching, redness
and contact dermatitis), particularly in children with atopic eczema.
The package leaflet/label should include the following information:
Contains sodium lauryl sulfate which may cause local skin reactions
(e.g.
stinging and contact dermatitis).
The risk of fire should be considered when using large quantities of
any
paraffin-based emollient. Emulsifying ointment in contact with
dressings and
clothing is easily ignited by a naked flame. The risk is greater when
this
preparation is applied to large areas of the body and clothing or
dressings
become soaked with the emollient. Patients should be told to keep away
from
fire or flames and not to smoke when using this preparation.
This preparation may make skin and surfaces slippery – particular
care is
needed when bathing.
Instruct patients not to smoke or go near naked flames - risk of
severe burns.
Fabric (clothing, bedding, dressings etc) that has been in contact
with this
product burns mo